J 2023

Hypertension treatment in patients with sleep apnea from the European Sleep Apnea Database (ESADA) cohort - towards precision medicine

SVEDMYR, Sven, Jan HEDNER, Maria Rosaria BONSIGNORE, Carolina LOMBARDI, Gianfranco PARATI et. al.

Základní údaje

Originální název

Hypertension treatment in patients with sleep apnea from the European Sleep Apnea Database (ESADA) cohort - towards precision medicine

Autoři

SVEDMYR, Sven (garant), Jan HEDNER, Maria Rosaria BONSIGNORE, Carolina LOMBARDI, Gianfranco PARATI, Ondřej LUDKA (203 Česká republika, domácí), Ding ZOU a Ludger GROTE

Vydání

Journal of Sleep Research, HOBOKEN, WILEY, 2023, 0962-1105

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30210 Clinical neurology

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 4.400 v roce 2022

Kód RIV

RIV/00216224:14110/23:00130273

Organizační jednotka

Lékařská fakulta

UT WoS

000899297400001

Klíčová slova anglicky

antihypertensive treatment; beta-blocker; blood pressure control; diuretic; hypertension; obstructive sleep apnea

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 15. 11. 2023 07:41, Mgr. Tereza Miškechová

Anotace

V originále

We recruited 5,970 patients with hypertension with obstructive sleep apnea (OSA) on current antihypertensive treatment from the European Sleep Apnea Database (ESADA) cohort. The group was subdivided into those receiving monotherapy (n = 3,594) and those receiving dual combined therapy (n = 2,376). We studied how major OSA confounders like age, gender, and body mass index as well as the degree of sleep apnea modified office systolic and diastolic blood pressure. Beta-blockers alone or in combination with a diuretic were compared with other antihypertensive drug classes. Monotherapy with beta-blocker was associated with lower systolic blood pressure, particularly in non-obese middle-aged males with hypertension. Conversely, the combination of a beta-blocker and a diuretic was associated with lower systolic and diastolic blood pressure in patients with hypertension with moderate-severe OSA. Systolic blood pressure was better controlled in female patients using this combined treatment. Our cross-sectional data suggest that specific clinical characteristics and type of antihypertensive medication influence the degree of blood pressure control in patients with hypertension with OSA. Controlled trials are warranted.